Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Journal of Hematology & Oncology|March 31, 2020
The role of cancer-derived microRNAs in cancer immune escapeMing Yi, Linping Xu, Ying Jiao, et al.Oncology Letters|March 20, 2015
A preliminary study of the effect of curcumin on the expression of p53 protein in a human multiple myeloma cell lineWei Li, Yaomei Wang, Yongping Song, et al.Frontiers in Oncology|January 31, 2020
CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung CancerShengnan Yu, Ming Yi, Linping Xu, et al.Molecular Cancer|November 7, 2019
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4Shuang Qin, Linping Xu, Ming Yi, et al.Frontiers in Oncology|September 26, 2022
Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinomaLinping Xu, Meimei Yan, Jianpeng Long, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 5, 2020
CHAF1A overexpression in human retinoblastoma promotes cell proliferation and suppresses apoptosisJian Shen, Xudong Liu, Ming Zhou, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 7, 2008
Determination of salirasib (S-trans,trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography-tandem mass spectrometryMing Zhao, Ping He, Linping Xu, et al.Journal of Immunology Research|September 16, 2017
Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-<i>α</i> in Chinese Resected Stage III Malignant MelanomaWei Li, Linping Xu, Yaomei Wang, et al.Oncology Letters|June 28, 2016
Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinomaWei Li, Yaomei Wang, Daniel B Kellner, et al.Expert Opinion on Investigational Drugs|August 22, 2020
CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancersYing Jiao, Ming Yi, Linping Xu, et al.Pageof 6